- Home
- NVGS vs OPK Comparison
NVGS vs OPK Comparison
Compare NVGS & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVGS
- OPK
- Stock Information
- Founded
- NVGS 1997
- OPK 2007
- Country
- NVGS United Kingdom
- OPK United States
- Employees
- NVGS N/A
- OPK N/A
- Industry
- NVGS Marine Transportation
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- NVGS Consumer Discretionary
- OPK Health Care
- Exchange
- NVGS Nasdaq
- OPK Nasdaq
- Market Cap
- NVGS 1.1B
- OPK 1.0B
- IPO Year
- NVGS N/A
- OPK 1995
- Fundamental
- Price
- NVGS $17.03
- OPK $1.58
- Analyst Decision
- NVGS Strong Buy
- OPK Strong Buy
- Analyst Count
- NVGS 3
- OPK 3
- Target Price
- NVGS $22.00
- OPK $2.75
- AVG Volume (30 Days)
- NVGS 218.6K
- OPK 2.9M
- Earning Date
- NVGS 03-12-2025
- OPK 02-25-2025
- Dividend Yield
- NVGS 1.18%
- OPK N/A
- EPS Growth
- NVGS 13.48
- OPK N/A
- EPS
- NVGS 1.12
- OPK N/A
- Revenue
- NVGS $564,280,000.00
- OPK $711,408,000.00
- Revenue This Year
- NVGS $0.05
- OPK N/A
- Revenue Next Year
- NVGS $4.76
- OPK $0.00
- P/E Ratio
- NVGS $14.81
- OPK N/A
- Revenue Growth
- NVGS 5.99
- OPK N/A
- 52 Week Low
- NVGS $14.55
- OPK $0.86
- 52 Week High
- NVGS $18.18
- OPK $1.76
- Technical
- Relative Strength Index (RSI)
- NVGS 54.83
- OPK 55.91
- Support Level
- NVGS $15.92
- OPK $1.47
- Resistance Level
- NVGS $17.52
- OPK $1.51
- Average True Range (ATR)
- NVGS 0.45
- OPK 0.04
- MACD
- NVGS -0.03
- OPK 0.01
- Stochastic Oscillator
- NVGS 40.62
- OPK 94.44
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture).
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.